I need to state a theoretical conflict of interests up front. I am a member of the Board of Directors of the International Myeloma Foundation. So, having said that …
Fred Baron, a well known Texas-based lawyer and the former finance chairman of John Edwards’s presidential campaign, has progressive multiple myeloma. I am not aware of the [...]
Filed under: Business strategy, Drug approvals and regulation, Health and drug costs | Tagged: Baron, ethics, FDA, myeloma, Tysabri | 1 Comment »
